Tobin T, Blake J W
Br J Sports Med. 1976 Oct;10(3):109-16. doi: 10.1136/bjsm.10.3.109.
Since procaine has both local anaesthetic and central stimulant actions its presence in the blood or urine of racing horses is forbidden. After rapid intravenous injection of procaine HC1 (2.5 mg/Kg) in thoroughbred mares plasma levels of this drug fell rapidly (t 1/2 alpha = 5 min) and then more slowly (t 1/2 beta = 50.2 min). These kinetics were well fitted by a two compartment open model (Model I). This model gave an apparent Vdbeta for procaine in the horse of about 3,500 litres. Since procaine was about 45% bound to equine plasma protein this gives a true Vdbeta for procaine of about 6,500 litres. After subcutaneous injection of procaine HC1 (3.3 mg/Kg) plasma levels peaked at about 400 ng/ml and then declined with a half-life of about 75 minutes. These data were well fitted by Model I when this was modified to include simple first order absorption (K = 0.048 min-1) from the subcutaneous injection site (Model II). After intramuscular injection of procaine penicillin (33,000 I.U./Kg) plasma levels reached a peak at about 270 ng/ml and then declined with a half-life of about 9 hours. These data were approximately fitted by Model II assuming a first order rate constant for absorption of procaine of 0.0024 min-1. After intramuscular injection of procaine HC1 (10 mg/Kg) plasma levels of procaine peaked rapidly at about 600 ng/ml but thereafter declined slowly (+ 1/2 = 2 hours). A satisfactory pharmaco-kinetic model for this intramuscular data could not be developed. An approximation of these data was obtained by assuming the existence of two intramuscular drug compartments, one containing readily absorbable drug and the other poorly absorbable drug (Model III). After intra-articular administration of procaine (0.33 mg/Kg) plasma levels of this drug reached a peak at about 17 ng/ml and then declined with a half-life of about 2 hours. These data were not modelled.
由于普鲁卡因具有局部麻醉和中枢兴奋作用,赛马血液或尿液中禁止出现该药物。给纯种母马快速静脉注射盐酸普鲁卡因(2.5毫克/千克)后,该药物的血浆水平迅速下降(t 1/2α = 5分钟),随后下降速度减慢(t 1/2β = 50.2分钟)。这些动力学数据与二室开放模型(模型I)拟合良好。该模型得出马体内普鲁卡因的表观分布容积β约为3500升。由于普鲁卡因约45%与马血浆蛋白结合,这使得普鲁卡因的真实分布容积β约为6500升。皮下注射盐酸普鲁卡因(3.3毫克/千克)后,血浆水平在约400纳克/毫升时达到峰值,然后以约75分钟的半衰期下降。当模型I修改为包括皮下注射部位的简单一级吸收(K = 0.048分钟-1)时(模型II),这些数据与该模型拟合良好。肌肉注射普鲁卡因青霉素(33,000国际单位/千克)后,血浆水平在约270纳克/毫升时达到峰值,然后以约9小时的半衰期下降。假设普鲁卡因的一级吸收速率常数为0.0024分钟-1,这些数据大致符合模型II。肌肉注射盐酸普鲁卡因(10毫克/千克)后,普鲁卡因的血浆水平迅速在约600纳克/毫升时达到峰值,但此后下降缓慢(+ 1/2 = 2小时)。无法为这些肌肉注射数据建立令人满意的药代动力学模型。通过假设存在两个肌肉内药物隔室,一个包含易于吸收的药物,另一个包含难以吸收的药物(模型III),获得了这些数据的近似值。关节内注射普鲁卡因(0.33毫克/千克)后,该药物的血浆水平在约17纳克/毫升时达到峰值,然后以约2小时的半衰期下降。这些数据未进行建模。